270 related articles for article (PubMed ID: 33545120)
1. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
Zhang Y; Liang B; Song X; Wang H; Evert M; Zhou Y; Calvisi DF; Tang L; Chen X
Am J Pathol; 2021 May; 191(5):930-946. PubMed ID: 33545120
[TBL] [Abstract][Full Text] [Related]
2. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
[TBL] [Abstract][Full Text] [Related]
3. TMEM9-v-ATPase Activates Wnt/β-Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis.
Jung YS; Stratton SA; Lee SH; Kim MJ; Jun S; Zhang J; Zheng B; Cervantes CL; Cha JH; Barton MC; Park JI
Hepatology; 2021 Feb; 73(2):776-794. PubMed ID: 32380568
[TBL] [Abstract][Full Text] [Related]
4. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
5. Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.
Ueberham E; Glöckner P; Göhler C; Straub BK; Teupser D; Schönig K; Braeuning A; Höhn AK; Jerchow B; Birchmeier W; Gaunitz F; Arendt T; Sansom O; Gebhardt R; Ueberham U
Mol Cancer Res; 2015 Feb; 13(2):239-49. PubMed ID: 25270420
[TBL] [Abstract][Full Text] [Related]
6. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
[TBL] [Abstract][Full Text] [Related]
7. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
8. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Hu PJ; Knoepp SM; Wu R; Cho KR
Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
10. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.
Curia MC; Zuckermann M; De Lellis L; Catalano T; Lattanzio R; Aceto G; Veschi S; Cama A; Otte JB; Piantelli M; Mariani-Costantini R; Cetta F; Battista P
Mod Pathol; 2008 Jan; 21(1):7-14. PubMed ID: 17962810
[TBL] [Abstract][Full Text] [Related]
11. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
[TBL] [Abstract][Full Text] [Related]
12. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA
Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
15. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
16. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
18. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
19. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
Dubbink HJ; Hollink IHIM; Avenca Valente C; Wang W; Liu P; Doukas M; van Noesel MM; Dinjens WNM; Wagner A; Smits R
Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530
[TBL] [Abstract][Full Text] [Related]
20. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
